Novel inhibitors of leukotrienes /

Bibliographic Details
Other Authors: Folco, Giancarlo, Samuelsson, Bengt, Murphy, Robert C.
Format: Book
Language:English
Published: Basel ; Boston : Birkhäuser Verlag, [1999]
Series:PIR (Series)
Subjects:
Table of Contents:
  • 5-lipoxygenase / Olof P. Rådmark
  • LTC₄ synthase: a key enzyme in cysteinyl leukotriene formation / John F. Penrose, K. Frank Austen, Bing K. Lam
  • Leukotriene A₄ hydrolase: a key enzyme in chemotactic leukotriene formation / Jesper Z. Haeggström, Anders Wetterholm
  • Metabolism of leukotrienes and formation of new leukotriene structures / Robert C. Murphy, Joseph A. Hankin
  • Receptors for cysteinyl-leukotrienes: targets for new drugs / Simonetta Nicosia
  • Targeted disruption of 5-lipoxygenase / Colin D. Funk
  • Transcellular biosynthesis of leukotrienes: a unique mode of cell communication / Angelo Sala, Jacques Maclouf
  • Physiological and pathophysiological activities of leukotrienes / Per O. Hedqvist, Lennart J.O. Lindbom
  • Entry rate and metabolic handling of LTC₄ in the human circulation / Carlo Patrono
  • Genetic polymorphisms of 5-LO / Eric S. Silverman ... [et al.]
  • Leukotrienes and aspirin-intolerant asthma / Andrzej Szczeklik, Marek Sanak
  • Leukotrienes in nocturnal asthma / Sally E. Wenzel
  • Leukotrienes and allergic asthma / Barbro Dahlén, Sven-Erik Dahlén
  • Inhibitors of leukotrienes: an overview / Giancarlo Folco
  • The development of zafirlukast (Accolate) and the Zeneca series of peptidyl-leukotriene receptor antagonists / Peter R. Bernstein
  • The development of zileuton (ZYFLO) and the N-hydroxyurea class of 5-lipoxygenase inhibitors / Randy L. Bell
  • The development of BAY X 1005 and the Bayer series of leukotriene biosynthesis inhibitors / Reiner Müller-Peddinghaus, Bodo Junge, Wiebke Langhans
  • The development of iralukast: a member of the Novartis series of cysteinyl leukotriene antagonists / Uwe P. Tittmann ... [et al.]
  • LTB₄ receptor antagonists / William T. Jackson
  • SmithKline Beecham pharmaceuticals' cysteinyl leukotriene receptor antagonists: Pranlukast (SB 205312; Ono-1078; Onon), Pobilukast (SK&F 104353) and SK&F 106203 / Douglas W.P. Hay.